Taiping Hospital, formerly known as Yong Wah Hospital was one of the first hospitals established in Malaysia. Located at Jalan Taming Sari near the commercial town centre, it is one of the biggest hospitals in Malaysia and is the second biggest in the State of Perak.

There are 608 beds in Hospital Taiping.

During the past decade, Hospital Taiping conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 11 clinical trials were completed, i.e. on average, 73.3% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 10 clinical trials were completed. i.e. 166.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hospital Taiping" #1 sponsor was "Janssen Research & Development, LLC" with 5 trials, followed by "Allergan" with 4 trials sponsored, "Ministry of Health, Malaysia" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Boehringer Ingelheim" with 3 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Taiping" #1 collaborator was "Eli Lilly and Company" with 2 trials as a collaborator and "Canadian Institutes of Health Research (CIHR)" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Taiping" are "Gastroparesis" (4 trials), "Diabetes Mellitus" (3 trials), "Diabetes Mellitus, Type 2" (2 trials), "Influenza A" (2 trials) and "Adnexal Mass" (1 trials). Many other conditions were trialed in "Hospital Taiping" in a lesser frequency.

Most popular intervention types in "Hospital Taiping" are "Drug" (16 trials), "Diagnostic Test" (2 trials), "Other" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Relamorelin" (3 trials), "Pimodivir 600 mg" (2 trials), "SOC Treatment" (2 trials) and "Blank Preparation of Recombinant SARS-CoV-2 Fusion Protein Vaccine (V-01)" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Taiping" are 19 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Hospital Taiping". 1 are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Hospital Taiping, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Taiping, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 12 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".